These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14513853)

  • 41. Opportunities and options for treatment research in resource-constrained settings.
    Volberding PA
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S1-3. PubMed ID: 12822126
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV prevention and treatment in Africa.
    Laurence J
    AIDS Patient Care STDS; 2000 Aug; 14(8):399-400. PubMed ID: 10977967
    [No Abstract]   [Full Text] [Related]  

  • 43. Stirring the statistical pot.
    Bateman C
    S Afr Med J; 2004 Mar; 94(3):154-5. PubMed ID: 15098266
    [No Abstract]   [Full Text] [Related]  

  • 44. Evolution of HIV disease in the third millennium: clinical and related economic issues.
    Manfredi R
    Int J Antimicrob Agents; 2002 Mar; 19(3):251-3. PubMed ID: 11932152
    [No Abstract]   [Full Text] [Related]  

  • 45. [HIV treatment by ARV in resource-poor francophone countries].
    Lepère P; Milleliri JM
    Med Sante Trop; 2015; 25(3):237-44. PubMed ID: 26446740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [HIV eradication--facts and fiction].
    Jaeger H; Wolf E
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract]   [Full Text] [Related]  

  • 47. [HIV vaccination].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():68-9. PubMed ID: 19031568
    [No Abstract]   [Full Text] [Related]  

  • 48. [Costs and cost-efficacy analysis of the preferred treatments by GESIDA/National Plan for AIDS for the initial antiretroviral therapy in adult human immunodeficiency virus (HIV) infected patients in 2012].
    Blasco AJ; Arribas JR; Boix V; Clotet B; Domingo P; González-García J; Knobel H; López JC; Llibre JM; Lozano F; Miró JM; Podzamczer D; Santamaría JM; Tuset M; Zamora L; Lázaro P; Gatell JM;
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):283-93. PubMed ID: 22525829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 25 years after HIV discovery: prospects for cure and vaccine.
    Montagnier L
    Virology; 2010 Feb; 397(2):248-54. PubMed ID: 20152474
    [No Abstract]   [Full Text] [Related]  

  • 50. Simplifying and adapting antiretroviral treatment in resource-poor settings: a necessary step to scaling-up.
    Calmy A; Klement E; Teck R; Berman D; Pécoul B; Ferradini L
    AIDS; 2004 Dec; 18(18):2353-60. PubMed ID: 15622311
    [No Abstract]   [Full Text] [Related]  

  • 51. Antiretroviral therapy in children--increased benefit from increased complexity.
    Cotton MF
    S Afr Med J; 2000 Oct; 90(10):985-8. PubMed ID: 11081099
    [No Abstract]   [Full Text] [Related]  

  • 52. HIV/AIDS: Latin America & Caribbean. Dominican Republic: a sour taste on the sugar plantations.
    Cohen J
    Science; 2006 Jul; 313(5786):473-5. PubMed ID: 16873642
    [No Abstract]   [Full Text] [Related]  

  • 53. Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.
    Elliott JH; Lynen L; Calmy A; De Luca A; Shafer RW; Zolfo M; Clotet B; Huffam S; Boucher CA; Cooper DA; Schapiro JM
    AIDS; 2008 Oct; 22(16):2053-67. PubMed ID: 18753937
    [No Abstract]   [Full Text] [Related]  

  • 54. Feasibility and cohort development for HIV vaccine trials in Haiti.
    Deschamps MM; Johnson WD; Pape JW
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S231-3. PubMed ID: 7865308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 56. An uncomfortable truth: AIDS vaccine trials must continue.
    Schüklenk U
    Dev World Bioeth; 2008 Aug; 8(2):ii-iii. PubMed ID: 19143082
    [No Abstract]   [Full Text] [Related]  

  • 57. HIV/AIDS: Latin America & Caribbean. HAITI: making headway under hellacious circumstances.
    Cohen J
    Science; 2006 Jul; 313(5786):470-3. PubMed ID: 16873641
    [No Abstract]   [Full Text] [Related]  

  • 58. Therapies. The high cost of poverty.
    Cohen J
    Science; 2002 Jun; 296(5577):2324. PubMed ID: 12089424
    [No Abstract]   [Full Text] [Related]  

  • 59. Are the best antiretrovirals being used in Africa?
    John L; Kambugu A; Songa PM; Castelnuovo B; Colebunders R; Kamya M
    J HIV Ther; 2006 Mar; 11(1):11-5. PubMed ID: 16706250
    [No Abstract]   [Full Text] [Related]  

  • 60. HIV antiretroviral therapy in resource-limited settings: experiences from Haiti.
    Krain A; Fitzgerald DW
    Curr HIV/AIDS Rep; 2005 Jun; 2(2):98-104. PubMed ID: 16091255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.